{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:44:26Z","timestamp":1788443066143,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Six Talent Peaks Project in Jiangsu Province, China","award":["2019, WSN-049"],"award-info":[{"award-number":["2019, WSN-049"]}]},{"name":"the Six Talent Peaks Project in Jiangsu Province, China","award":["2019, WSN-049"],"award-info":[{"award-number":["2019, WSN-049"]}]},{"name":"the Six Talent Peaks Project in Jiangsu Province, China","award":["2019, WSN-049"],"award-info":[{"award-number":["2019, WSN-049"]}]},{"name":"the Six Talent Peaks Project in Jiangsu Province, China","award":["2019, WSN-049"],"award-info":[{"award-number":["2019, WSN-049"]}]},{"name":"the Six Talent Peaks Project in Jiangsu Province, China","award":["2019, WSN-049"],"award-info":[{"award-number":["2019, WSN-049"]}]},{"name":"\u201c333 Project\u201d of Jiangsu Province"},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","award":["Nursing Science, 2018, No.87"],"award-info":[{"award-number":["Nursing Science, 2018, No.87"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","award":["Nursing Science, 2018, No.87"],"award-info":[{"award-number":["Nursing Science, 2018, No.87"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","award":["Nursing Science, 2018, No.87"],"award-info":[{"award-number":["Nursing Science, 2018, No.87"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","award":["Nursing Science, 2018, No.87"],"award-info":[{"award-number":["Nursing Science, 2018, No.87"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","award":["Nursing Science, 2018, No.87"],"award-info":[{"award-number":["Nursing Science, 2018, No.87"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research and Innovation Team Project of School of Nursing, Nanjing Medical University"},{"name":"Wisdom Kangyang Industry Institute Key Research Project, Nanjing Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-024-01457-y","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T08:27:49Z","timestamp":1726043269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["High-density lipoprotein cholesterol trajectory and new-onset metabolic dysfunction-associated fatty liver disease incidence: a longitudinal study"],"prefix":"10.1186","volume":"16","author":[{"given":"Mengting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongchun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"1457_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:202\u20139. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32278004.","journal-title":"J Hepatol"},{"key":"1457_CR2","doi-asserted-by":"crossref","unstructured":"Paik JM, Henry L, De Avila L, Younossi E, Racila A, Younossi ZM. Mortality related to nonalcoholic fatty liver disease is increasing in the United States. Hepatol Commun 2019, 3:1459\u201371https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31701070","DOI":"10.1002\/hep4.1419"},{"key":"1457_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","volume":"17","author":"M Eslam","year":"2020","unstructured":"Eslam M, George J. Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology. Nat Rev Gastroenterol Hepatol. 2020;17:40\u201352. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31641249.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1457_CR4","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62:S47\u201364. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25920090.","journal-title":"J Hepatol"},{"key":"1457_CR5","doi-asserted-by":"crossref","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol 2016, 65:589\u2013600https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27212244","DOI":"10.1016\/j.jhep.2016.05.013"},{"key":"1457_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol. 2019;70:531\u201344. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30414863.","journal-title":"J Hepatol"},{"key":"1457_CR7","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41575-022-00635-5","volume":"19","author":"M Eslam","year":"2022","unstructured":"Eslam M, El-Serag HB, Francque S, Sarin SK, Wei L, Bugianesi E, George J. Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight. Nat Rev Gastroenterol Hepatol. 2022;19:638\u201351. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35710982.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1457_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.hbpd.2022.01.006","volume":"21","author":"J Zeng","year":"2022","unstructured":"Zeng J, Qin L, Jin Q, Yang RX, Ning G, Su Q, Yang Z, Fan JG. Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: a community-based study. Hepatobiliary Pancreat Dis Int. 2022;21:154\u201361. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35153138.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"1457_CR9","doi-asserted-by":"publisher","first-page":"e745","DOI":"10.1210\/clinem\/dgab644","volume":"107","author":"X Wang","year":"2022","unstructured":"Wang X, Wu S, Yuan X, Chen S, Fu Q, Sun Y, Lan Y, Hu S, Wang Y, Lu Y, et al. Metabolic dysfunction-associated fatty liver disease and mortality among Chinese adults: a prospective cohort study. J Clin Endocrinol Metab. 2022;107:e745\u201355. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34467980.","journal-title":"J Clin Endocrinol Metab"},{"key":"1457_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1210\/clinem\/dgab641","volume":"107","author":"Y Liang","year":"2022","unstructured":"Liang Y, Chen H, Liu Y, Hou X, Wei L, Bao Y, Yang C, Zong G, Wu J, Jia W. Association of MAFLD with Diabetes, chronic kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China. J Clin Endocrinol Metab. 2022;107:88\u201397. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34508601.","journal-title":"J Clin Endocrinol Metab"},{"key":"1457_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12986-021-00611-x","volume":"18","author":"J Fan","year":"2021","unstructured":"Fan J, Luo S, Ye Y, Ju J, Zhang Z, Liu L, Yang J, Xia M. Prevalence and risk factors of metabolic associated fatty liver disease in the contemporary South China population. Nutr Metab (Lond). 2021;18:82. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34496912.","journal-title":"Nutr Metab (Lond)"},{"key":"1457_CR12","doi-asserted-by":"crossref","unstructured":"Li H, Guo M, An Z, Meng J, Jiang J, Song J, Wu W. Prevalence and risk factors of metabolic Associated fatty liver disease in Xinxiang, China. Int J Environ Res Public Health. 2020;17. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32168920","DOI":"10.3390\/ijerph17061818"},{"key":"1457_CR13","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P, She ZG, Zhu L, Cai J, Li H. Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatology. 2020;71:1851\u201364.","journal-title":"Hepatology"},{"key":"1457_CR14","doi-asserted-by":"crossref","unstructured":"Barber TM, Kabisch S, Pfeiffer AFH, Weickert MO. Metabolic-Associated fatty liver disease and insulin resistance: a review of Complex interlinks. Metabolites. 2023;13. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37367914","DOI":"10.3390\/metabo13060757"},{"key":"1457_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fmed.2020.00467","volume":"7","author":"P Malhotra","year":"2020","unstructured":"Malhotra P, Gill RK, Saksena S, Alrefai WA. Disturbances in Cholesterol Homeostasis and non-alcoholic fatty liver diseases. Front Med (Lausanne). 2020;7:467. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32984364.","journal-title":"Front Med (Lausanne)"},{"key":"1457_CR16","doi-asserted-by":"publisher","first-page":"100322","DOI":"10.1016\/j.jhepr.2021.100322","volume":"3","author":"SM Francque","year":"2021","unstructured":"Francque SM, Marchesini G, Kautz A, Walmsley M, Dorner R, Lazarus JV, Zelber-Sagi S, Hallsworth K, Busetto L, Fruhbeck G, et al. Non-alcoholic fatty liver disease: a patient guideline. JHEP Rep. 2021;3:100322. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34693236.","journal-title":"JHEP Rep"},{"key":"1457_CR17","doi-asserted-by":"publisher","first-page":"101146","DOI":"10.1016\/j.molmet.2020.101146","volume":"50","author":"DY Vos","year":"2021","unstructured":"Vos DY, van de Sluis B. Function of the endolysosomal network in cholesterol homeostasis and metabolic-associated fatty liver disease (MAFLD). Mol Metab. 2021;50:101146.","journal-title":"Mol Metab"},{"key":"1457_CR18","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez-Cuevas J, Lucano-Landeros S, L\u00f3pez-Cifuentes D, Santos A, Armendariz-Borunda J. Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies. Cancers (Basel). 2022;15.","DOI":"10.3390\/cancers15010023"},{"key":"1457_CR19","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez-Cuevas J, Santos A, Armendariz-Borunda J. Pathophysiological molecular mechanisms of obesity: a link between MAFLD and NASH with Cardiovascular diseases. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms222111629"},{"key":"1457_CR20","doi-asserted-by":"crossref","unstructured":"Mocciaro G, Allison M, Jenkins B, Azzu V, Huang-Doran I, Herrera-Marcos LV, Hall Z, Murgia A, Susan D, Frontini M et al. Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL). Mol Metab. 2023;73:101728https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37084865","DOI":"10.1016\/j.molmet.2023.101728"},{"key":"1457_CR21","doi-asserted-by":"publisher","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","volume":"50","author":"J Heeren","year":"2021","unstructured":"Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab. 2021;50:101238. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33892169.","journal-title":"Mol Metab"},{"key":"1457_CR22","doi-asserted-by":"crossref","unstructured":"Konings M, Baumgartner S, Mensink RP, Plat J. Investigating microRNAs to explain the link between Cholesterol Metabolism and NAFLD in humans: a systematic review. Nutrients; 2022. p. 14.","DOI":"10.3390\/nu14234946"},{"key":"1457_CR23","doi-asserted-by":"crossref","unstructured":"Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, Hirschhorn JN, O\u2019Donnell CJ, Fox CS. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology. 2010;51:1979\u201387. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20336705.","DOI":"10.1002\/hep.23593"},{"key":"1457_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","volume":"227","author":"AP DeFilippis","year":"2013","unstructured":"DeFilippis AP, Blaha MJ, Martin SS, Reed RM, Jones SR, Nasir K, Blumenthal RS, Budoff MJ. Nonalcoholic fatty liver disease and serum lipoproteins: the multi-ethnic study of atherosclerosis. Atherosclerosis. 2013;227:429\u201336. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23419204.","journal-title":"Atherosclerosis"},{"key":"1457_CR25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jacl.2015.12.026","volume":"10","author":"KT Wu","year":"2016","unstructured":"Wu KT, Kuo PL, Su SB, Chen YY, Yeh ML, Huang CI, Yang JF, Lin CI, Hsieh MH, Hsieh MY, et al. Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol. J Clin Lipidol. 2016;10:420\u2013e425421. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27055973.","journal-title":"J Clin Lipidol"},{"key":"1457_CR26","doi-asserted-by":"crossref","unstructured":"Feng G, Feng L, Zhao Y. Association between ratio of gamma-glutamyl transpeptidase to high-density lipoprotein cholesterol and prevalence of nonalcoholic fatty liver disease and metabolic syndrome: a cross-sectional study. Ann Transl Med. 2020;8:634https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32566571","DOI":"10.21037\/atm-19-4516"},{"key":"1457_CR27","doi-asserted-by":"publisher","first-page":"7557","DOI":"10.1038\/s41598-018-25641-z","volume":"8","author":"J Wu","year":"2018","unstructured":"Wu J, He S, Xu H, Chi X, Sun J, Wang X, Gao X, Wu R, Shao M, Zhao H, et al. Non-alcoholic fatty liver disease incidence, remission and risk factors among a general Chinese population with a 6-year follow-up. Sci Rep. 2018;8:7557. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29765064.","journal-title":"Sci Rep"},{"key":"1457_CR28","doi-asserted-by":"crossref","unstructured":"Ren XY, Shi D, Ding J, Cheng ZY, Li HY, Li JS, Pu HQ, Yang AM, He CL, Zhang JP et al. Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study. Lipids Health Dis, 2019;18:47https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30744645","DOI":"10.1186\/s12944-019-0984-9"},{"key":"1457_CR29","doi-asserted-by":"publisher","first-page":"100627","DOI":"10.1016\/j.jhepr.2022.100627","volume":"5","author":"L Crudele","year":"2023","unstructured":"Crudele L, De Matteis C, Piccinin E, Gadaleta RM, Cariello M, Di Buduo E, Piazzolla G, Suppressa P, Berardi E, Sabba C, Moschetta A. Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis. JHEP Rep. 2023;5:100627. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36561127.","journal-title":"JHEP Rep"},{"key":"1457_CR30","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","volume":"65","author":"N Katsiki","year":"2016","unstructured":"Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: an update. Metabolism. 2016;65:1109\u201323. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27237577.","journal-title":"Metabolism"},{"key":"1457_CR31","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.32728","volume":"77","author":"J Xie","year":"2023","unstructured":"Xie J, Huang H, Liu Z, Li Y, Yu C, Xu L, Xu C. The associations between modifiable risk factors and nonalcoholic fatty liver disease: a comprehensive mendelian randomization study. Hepatology. 2023;77:949\u201364. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35971878.","journal-title":"Hepatology"},{"key":"1457_CR32","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.3748\/wjg.v25.i24.3009","volume":"25","author":"JM Mato","year":"2019","unstructured":"Mato JM, Alonso C, Noureddin M, Lu SC. Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. World J Gastroenterol. 2019;25:3009\u201320. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31293337.","journal-title":"World J Gastroenterol"},{"key":"1457_CR33","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1177\/0049124113503141","volume":"42","author":"BL Jones","year":"2013","unstructured":"Jones BL, Nagin DS. A note on a Stata Plugin for Estimating Group-based Trajectory models. Sociol Methods Res. 2013;42:608\u201313. :\/\/WOS:000330315100007.","journal-title":"Sociol Methods Res"},{"key":"1457_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109\u201338. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20192788.","journal-title":"Annu Rev Clin Psychol"},{"key":"1457_CR35","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1177\/0962280216673085","volume":"27","author":"DS Nagin","year":"2018","unstructured":"Nagin DS, Jones BL, Passos VL, Tremblay RE. Group-based multi-trajectory modeling. Stat Methods Med Res. 2018;27:2015\u201323. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29846144.","journal-title":"Stat Methods Med Res"},{"key":"1457_CR36","doi-asserted-by":"crossref","unstructured":"Tian T, Zhang J, Xie W, Ni Y, Fang X, Liu M, Peng X, Wang J, Dai Y, Zhou Y. Dietary Quality and relationships with Metabolic Dysfunction-Associated fatty liver Disease (MAFLD) among United States adults, results from NHANES 2017\u20132018. Nutrients; 2022. p. 14.","DOI":"10.3390\/nu14214505"},{"key":"1457_CR37","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.cgh.2021.11.038","volume":"21","author":"GEH Lim","year":"2023","unstructured":"Lim GEH, Tang A, Ng CH, Chin YH, Lim WH, Tan DJH, Yong JN, Xiao J, Lee CW, Chan M, et al. An Observational Data Meta-Analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD. Clin Gastroenterol Hepatol. 2023;21:619\u2013e629617.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1457_CR38","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7:851\u201361. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35798021.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1457_CR39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"2019","unstructured":"Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019;4:389\u201398. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30902670.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1457_CR40","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ajg.2016.178","volume":"111","author":"Y Chang","year":"2016","unstructured":"Chang Y, Jung HS, Cho J, Zhang Y, Yun KE, Lazo M, Pastor-Barriuso R, Ahn J, Kim CW, Rampal S, et al. Metabolically healthy obesity and the development of nonalcoholic fatty liver disease. Am J Gastroenterol. 2016;111:1133\u201340. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27185080.","journal-title":"Am J Gastroenterol"},{"key":"1457_CR41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2014.08.041","volume":"62","author":"VW Wong","year":"2015","unstructured":"Wong VW, Wong GL, Yeung DK, Lau TK, Chan CK, Chim AM, Abrigo JM, Chan RS, Woo J, Tse YK, et al. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. J Hepatol. 2015;62:182\u20139. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25195550.","journal-title":"J Hepatol"},{"key":"1457_CR42","doi-asserted-by":"crossref","unstructured":"Lee YC, Chien KL, Lee BC, Lin HJ, Hsu HC, Chen MF. High-density lipoprotein-cholesterol trajectory pattern, associated lifestyle and biochemical factors among Taiwanese. Circ J. 2009;73:1887\u201392https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19661721","DOI":"10.1253\/circj.CJ-09-0209"},{"key":"1457_CR43","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.2147\/IJGM.S319759","volume":"14","author":"L Ji","year":"2021","unstructured":"Ji L, Cai X, Bai Y, Li T. Application of a Novel Prediction Model for Predicting 2-Year risk of non-alcoholic fatty liver disease in the non-obese Population with normal blood lipid levels: a large prospective cohort study from China. Int J Gen Med. 2021;14:2909\u201322. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34234521.","journal-title":"Int J Gen Med"},{"key":"1457_CR44","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2147\/DMSO.S342505","volume":"15","author":"Y Xing","year":"2022","unstructured":"Xing Y, Chen J, Liu J, Ma H. Associations between GGT\/HDL and MAFLD: a cross-sectional study. Diabetes Metab Syndr Obes. 2022;15:383\u201394. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35177915.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1457_CR45","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s12876-021-02038-3","volume":"21","author":"B Amernia","year":"2021","unstructured":"Amernia B, Moosavy SH, Banookh F, Zoghi G. FIB-4, APRI, and AST\/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran. BMC Gastroenterol. 2021;21:453. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34861841.","journal-title":"BMC Gastroenterol"},{"key":"1457_CR46","doi-asserted-by":"crossref","unstructured":"Cho J, Hong H, Park S, Kim S, Kang H. Insulin Resistance and its Association with metabolic syndrome in Korean Children. Biomed Res Int. 2017;2017:8728017https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29457038","DOI":"10.1155\/2017\/8728017"},{"key":"1457_CR47","doi-asserted-by":"crossref","unstructured":"Di Costanzo A, Ronca A, D\u2019Erasmo L, Manfredini M, Baratta F, Pastori D, Di Martino M, Ceci F, Angelico F, Del Ben M et al. HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD). Biomedicines, 2020;8.https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33352841","DOI":"10.3390\/biomedicines8120625"},{"key":"1457_CR48","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1111\/liv.14597","volume":"40","author":"BJ Verwer","year":"2020","unstructured":"Verwer BJ, Scheffer PG, Vermue RP, Pouwels PJ, Diamant M, Tushuizen ME. NAFLD is related to post-prandial triglyceride-enrichment of HDL Particles in Association with endothelial and HDL dysfunction. Liver Int. 2020;40:2439\u201344. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32652824.","journal-title":"Liver Int"},{"key":"1457_CR49","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4254\/wjh.v6.i5.274","volume":"6","author":"JJ Pan","year":"2014","unstructured":"Pan JJ, Fallon MB. Gender and racial differences in nonalcoholic fatty liver disease. World J Hepatol. 2014;6:274\u201383. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24868321.","journal-title":"World J Hepatol"},{"key":"1457_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28930295.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1457_CR51","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye Q, Zou B, Yeo YH, Li J, Huang DQ, Wu Y, Yang H, Liu C, Kam LY, Tan XXE, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:739\u201352. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32413340.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1457_CR52","doi-asserted-by":"crossref","unstructured":"Li Q, Han Y, Hu H, Zhuge Y. Gamma-Glutamyl transferase to high-density lipoprotein cholesterol ratio has a non-linear association with non-alcoholic fatty liver disease: a secondary prospective cohort study in non-obese Chinese adults. Front Med (Lausanne). 2022;9:995749https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36465946","DOI":"10.3389\/fmed.2022.995749"},{"key":"1457_CR53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12944-022-01661-7","volume":"21","author":"Z Liu","year":"2022","unstructured":"Liu Z, He H, Dai Y, Yang L, Liao S, An Z, Li S. Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study. Lipids Health Dis. 2022;21:55. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35752830.","journal-title":"Lipids Health Dis"},{"key":"1457_CR54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12944-019-0986-7","volume":"18","author":"N Fan","year":"2019","unstructured":"Fan N, Peng L, Xia Z, Zhang L, Song Z, Wang Y, Peng Y. Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study. Lipids Health Dis. 2019;18:39. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30711017.","journal-title":"Lipids Health Dis"},{"key":"1457_CR55","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/liv.12977","volume":"36","author":"Y Fukuda","year":"2016","unstructured":"Fukuda Y, Hashimoto Y, Hamaguchi M, Fukuda T, Nakamura N, Ohbora A, Kato T, Kojima T, Fukui M. Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study. Liver Int. 2016;36:713\u201320. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26444696.","journal-title":"Liver Int"},{"key":"1457_CR56","doi-asserted-by":"crossref","unstructured":"Kosekli MA, Kurtkulagii O, Kahveci G, Duman TT, Tel BMA, Bilgin S, Demirkol ME, Aktas G. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras (1992). 2021;67:549\u2013554.https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34495059","DOI":"10.1590\/1806-9282.20201005"},{"key":"1457_CR57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5551\/jat.64271","volume":"31","author":"T Hirano","year":"2024","unstructured":"Hirano T, Satoh N, Ito Y. Specific increase in small dense low-density lipoprotein-cholesterol levels beyond triglycerides in patients with diabetes: implications for Cardiovascular Risk of MAFLD. J Atheroscler Thromb. 2024;31:36\u201347.","journal-title":"J Atheroscler Thromb"},{"key":"1457_CR58","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/jdi.14148","volume":"15","author":"S Yang","year":"2024","unstructured":"Yang S, Xu J. Elevated small dense low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with an increased risk of metabolic dysfunction associated fatty liver disease in Chinese patients with type 2 diabetes mellitus. J Diabetes Investig. 2024;15:634\u201342.","journal-title":"J Diabetes Investig"},{"key":"1457_CR59","first-page":"483","volume":"26","author":"H Pan","year":"2021","unstructured":"Pan H, Liu J, Liu Y, Li H, Tao L, Ping Z, Xi G. Correlation between trajectories of high density lipoprotein cholesterol and the risk of diabetes in middle-aged and elderly population in Beijing. Chin J Cardiovasc Med. 2021;26:483\u20137.","journal-title":"Chin J Cardiovasc Med"}],"container-title":["Diabetology & Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-024-01457-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-024-01457-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-024-01457-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:15:34Z","timestamp":1732752934000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-024-01457-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1457"],"URL":"https:\/\/doi.org\/10.1186\/s13098-024-01457-y","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"assertion":[{"value":"20 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Ethics Review Board of Nanjing Medical University (Nanjing, China).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed written consents were obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"223"}}